Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood.

adenosine 5′-triphosphate binding cassette transporter A1 apolipoprotein A-I cholesterol flux cholesterol/metabolism erythrocyte high density lipoprotein lipidomics low density lipoprotein

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 11 9 2020
medline: 26 10 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Lipoproteins play a key role in transport of cholesterol to and from tissues. Recent studies have also demonstrated that red blood cells (RBCs), which carry large quantities of free cholesterol in their membrane, play an important role in reverse cholesterol transport. However, the exact role of RBCs in systemic cholesterol metabolism is poorly understood. RBCs were incubated with autologous plasma or isolated lipoproteins resulting in a significant net amount of cholesterol moved from RBCs to HDL, while cholesterol from LDL moved in the opposite direction. Furthermore, the bi-directional cholesterol transport between RBCs and plasma lipoproteins was saturable and temperature-, energy-, and time-dependent, consistent with an active process. We did not find LDLR, ABCG1, or scavenger receptor class B type 1 in RBCs but found a substantial amount of ABCA1 mRNA and protein. However, specific cholesterol efflux from RBCs to isolated apoA-I was negligible, and ABCA1 silencing with siRNA or inhibition with vanadate and Probucol did not inhibit the efflux to apoA-I, HDL, or plasma. Cholesterol efflux from and cholesterol uptake by RBCs from

Identifiants

pubmed: 32907987
pii: S0022-2275(20)60020-7
doi: 10.1194/jlr.RA120000635
pmc: PMC7707172
pii:
doi:

Substances chimiques

Lipoproteins 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1577-1588

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Nephrol Dial Transplant. 1999 May;14(5):1317-23
pubmed: 10344393
Cell Rep. 2016 Jun 28;16(1):186-200
pubmed: 27320924
J Lipid Res. 1997 Nov;38(11):2264-72
pubmed: 9392424
J Proteome Res. 2017 Aug 4;16(8):2752-2761
pubmed: 28689405
Cell. 2011 Jan 21;144(2):296-309
pubmed: 21241896
J Clin Invest. 1955 Sep;34(9):1345-53
pubmed: 13252080
J Lab Clin Med. 1955 Sep;46(3):359-71
pubmed: 13252314
J Biol Chem. 1996 Dec 27;271(52):33277-83
pubmed: 8969186
Chem Res Toxicol. 2013 Jun 17;26(6):918-25
pubmed: 23659204
Biol Chem. 2019 Nov 26;400(12):1593-1602
pubmed: 31188743
Ann Clin Lab Sci. 2001 Apr;31(2):151-6
pubmed: 11337904
J Am Coll Cardiol. 2007 May 29;49(21):2081-9
pubmed: 17531656
J Biol Chem. 2009 Aug 7;284(32):21192-200
pubmed: 19531471
Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):643-646
pubmed: 28232326
Transfusion. 2014 Apr;54(4):1146-52
pubmed: 23927791
Int J Med Sci. 2009;6(4):156-9
pubmed: 19421340
Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2260-2270
pubmed: 29074589
J Lipid Res. 1970 Nov;11(6):528-35
pubmed: 5504518
Nature. 2016 May 04;533(7604):561-4
pubmed: 27144356
J Lipid Res. 2013 Oct;54(10):2898-908
pubmed: 23868910
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1460-5
pubmed: 22499994
Nat Commun. 2017 Mar 30;8:14893
pubmed: 28358007
Caspian J Intern Med. 2017 Fall;8(4):305-310
pubmed: 29201323
J Am Coll Cardiol. 2002 Jul 3;40(1):27-33
pubmed: 12103252
PLoS One. 2016 Oct 7;11(10):e0164264
pubmed: 27716784
Cell Metab. 2016 Dec 13;24(6):783-794
pubmed: 27818259
J Biol Chem. 2015 Sep 25;290(39):23464-77
pubmed: 26198636
J Biol Chem. 2001 Feb 23;276(8):5467-75
pubmed: 11094054
Am J Hum Genet. 2017 May 4;100(5):706-724
pubmed: 28413018
J Lipid Res. 2015 Sep;56(9):1720-6
pubmed: 26203076
Cholesterol. 2014;2014:821686
pubmed: 25400944
J Biol Chem. 2007 Feb 2;282(5):2851-61
pubmed: 17121837
Exp Hematol. 2015 May;43(5):382-392
pubmed: 25681748
Biochim Biophys Acta. 2008 Jan;1778(1):175-84
pubmed: 18068686
Biochim Biophys Acta. 2012 Dec;1821(12):1493-500
pubmed: 22960544
Am J Physiol Heart Circ Physiol. 2014 Dec 15;307(12):H1737-44
pubmed: 25305182
Lancet. 2010 Jul 31;376(9738):333-9
pubmed: 20655105
Ups J Med Sci. 2012 Nov;117(4):390-8
pubmed: 23009223
Clin Biochem. 1986 Aug;19(4):229-34
pubmed: 3019588
J Lipid Res. 2005 Jan;46(1):86-92
pubmed: 15520449
J Am Heart Assoc. 2012 Aug;1(4):e001826
pubmed: 23130164
Exp Biol Med (Maywood). 2017 Jun;242(12):1244-1253
pubmed: 28436274

Auteurs

Ryunosuke Ohkawa (R)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Baker Heart and Diabetes Institute, Melbourne, Australia. Electronic address: ohkawa.alc@tmd.ac.jp.

Hann Low (H)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Nigora Mukhamedova (N)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Ying Fu (Y)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Shao-Jui Lai (SJ)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Mai Sasaoka (M)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Ayuko Hara (A)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Azusa Yamazaki (A)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Takahiro Kameda (T)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Yuna Horiuchi (Y)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Peter J Meikle (PJ)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Gerard Pernes (G)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Graeme Lancaster (G)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Michael Ditiatkovski (M)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Paul Nestel (P)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Boris Vaisman (B)

Lipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Denis Sviridov (D)

Lipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Andrew Murphy (A)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Alan T Remaley (AT)

Lipoprotein Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Dmitri Sviridov (D)

Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia. Electronic address: Dmitri.Sviridov@baker.edu.au.

Minoru Tozuka (M)

Department of Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Life Science Research Center, Nagano Children's Hospital, Azumino, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH